Parthenon Therapeutics
PrivateLast Round
Series A
Nov 3, 2021
Total Funding Raised
$65M
Company Overview
Parthenon Therapeutics is a biotechnology company that invents a novel class of anti-cancer therapies that reprogram the tumor microenvironment (TME).
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Parthenon Therapeutics Comparables
Compare Parthenon Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| ImmunoGenesis | 83% | |
| Apmonia Therapeutics | 78% | |
| Alentis Therapeutics | 74% |
Parthenon Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Nov 3, 2021 |
Parthenon Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| S32 | Series A |
| Creacion Ventures | Series A |
| Taiho Ventures | Series A |
| Northpond Ventures | Series A |
| Tekla Capital Management | Series A |
| Breakout Ventures | Series A |
| Alexandria Venture Investments | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 2, 2026
Monthly visitors increased 160% MoM, reaching 2K.
- Nov 9, 2024
Monthly visitors increased 40% MoM.
Parthenon Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Parthenon Therapeutics's valuation, stock price, and market status.
Is Parthenon Therapeutics a public or private company?
Parthenon Therapeutics is a private company.
What is the current stock price of Parthenon Therapeutics?
Parthenon Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is Parthenon Therapeutics worth (valuation)?
Valuation information for Parthenon Therapeutics is not publicly available.
Can I buy Parthenon Therapeutics stock?
Parthenon Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Parthenon Therapeutics's last funding round?
Parthenon Therapeutics's most recent funding round was Series A on November 3, 2021.
Who are the main investors in Parthenon Therapeutics?
Key investors in Parthenon Therapeutics include Taiho Ventures, Northpond Ventures, Pfizer Ventures.
Will Parthenon Therapeutics IPO soon?
No public IPO plans have been announced for Parthenon Therapeutics.
How can I track Parthenon Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Parthenon Therapeutics's secondary market activity and sign up for updates.